c-Met and Tie-2 antagonists (Angion)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namec-Met and Tie-2 antagonists (Angion)
Drug Alias Namecancer + rheumatoid arthritis therapy (Angion)ANG-1490ANG-797
ClassificationSmall molecules
Mechanisms of ActionHepatocyte growth factor receptor inhibitorsTEK receptor tyrosine kinase antagonistsAnticancer protein kinase inhibitors
TargetsTEK receptor tyrosine kinaseHepatocyte growth factor receptor
Therapy Area/IndicationsArthritis, RheumatoidNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesElicio Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesElicio Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsArthritis, RheumatoidNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A